• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

FDA

inHeart wins FDA clearance for 3D cardiac modeling software

May 24, 2022 By Sean Whooley

inHeart announced today that it received FDA 510(k) clearance for its inHeart Models software suite for cardiac modeling. France-based inHeart designed its inHeart Models software to enable the 3D visualization and analysis of anatomical structures for pre-procedural planning and intraprocedural use. FDA clearance allows for the expansion of the company’s commercial footprint in the U.S. […]

Filed Under: 510(k), Cardiovascular, Food & Drug Administration (FDA), Health Technology, Imaging, Regulatory/Compliance, Software / IT Tagged With: FDA, inHeart

FDA clears RapidAI’s pulmonary embolism triage platform

May 24, 2022 By Sean Whooley

RapidAI announced today that it received FDA 510(k) clearance for its Rapid PE Triage & Notification product. San Mateo, California-based RapidAI designed its Rapid PE Triage & Notification product for the fast identification and communication of suspected central pulmonary embolism (PE). According to a news release, Rapid PE Triage & Notification works in conjunction with […]

Filed Under: 510(k), Blood Management, Cardiovascular, Diagnostics, Digital Health, Food & Drug Administration (FDA), Health Technology, Regulatory/Compliance, Software / IT, Vascular Tagged With: FDA, RapidAI

Google Health hires FDA’s chief digital health officer

May 18, 2022 By Jim Hammerand

Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since […]

Filed Under: Big Data, Blog, Electronic Medical Records (EMR), Featured, Food & Drug Administration (FDA), Health Technology, News Well, Regulatory/Compliance, Software / IT Tagged With: AI, Alphabet, artificial intelligence, Cloud, cloud computing, FDA, Google, Google Health, machine learning

iRhythm stays silent on federal grand jury subpoenas

May 16, 2022 By Jim Hammerand

More than one year after receiving the first of two federal grand jury subpoenas seeking information about its products and communications with the FDA, iRhythm Technologies has said little publicly about the matter. It would have been easy to miss the San Francisco-based cardiac monitor maker’s initial disclosure last summer. iRhythm (Nasdaq:IRTC) was without a […]

Filed Under: Blog, Business/Financial News, Cardiovascular, Featured, Food & Drug Administration (FDA), Legal News, News Well, Regulatory/Compliance Tagged With: FDA, iRhythm Technologies

How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7

May 16, 2022 By Sean Whooley

A lot of talk around Dexcom (Nasdaq:DXCM) in the last couple of years has centered around its next-generation G7 continuous glucose monitor. The latest iteration of the company’s CGM platform has already garnered CE mark this year and awaits FDA approval, with some expectations for that to come after the American Diabetes Association’s Scientific Sessions next month. The company also presented […]

Filed Under: 510(k), Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Health Technology, Patient Monitoring, Regulatory/Compliance, Software / IT Tagged With: Dexcom, FDA

How Stryker includes users for product design in the digital age

May 13, 2022 By Jim Hammerand

Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial. Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them. The DeviceTalks Boston panel of Stryker […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, News Well, Orthopedics, Robotics, Software / IT, Surgical Tagged With: DeviceTalks Boston, FDA, Stryker, Vocera

FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent

May 13, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced today that it received FDA approval for its Onyx Frontier drug-eluting stent (DES). Onyx Frontier, the latest iteration of Medtronic’s Resolute DES family, was designed to leverage the same stent platform as Resolute with an enhanced delivery system for improving deliverability and increasing acute performance, even in the most challenging of cases. Get […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Drug-Device Combinations, Drug-Eluting Stents, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Stents, Structural Heart, Vascular Tagged With: FDA, Medtronic

Lucira Health asks FDA for EUA on molecular at-home COVID/flu test

May 12, 2022 By Jim Hammerand

Lucira Health (Nasdaq: LHDX) today said it has asked the FDA for an emergency use authorization (EUA) for its combination COVID-19 and flu test. Emeryville, California-based Lucira said the at-home test would be available with a prescription to test for SARS-CoV-2, Influenza A and Influenza B. The Nucleic Acid Amplification Test (NAAT) platform has a […]

Filed Under: Blog, Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, News Well, Regulatory/Compliance Tagged With: covid, COVID-19, FDA, influenza, Lucira, Lucira Health

FDA warns of potential toxic risk from Fresenius hemodialysis machines

May 9, 2022 By Jim Hammerand

The FDA is evaluating the risk of exposure to toxic chemicals from silicone tubing used in Fresenius Medical Care (NYSE: FMS) hemodialysis machines. The investigation concerns three models of Fresenius hemodialysis machines: the 2008T, 2008K2, and 2008K. The chemicals — non-dioxin-like (NDL) polychlorinated biphenyl acids (PCBAs) and NDL polychlorinated biphenyls (PCBs) — are in the […]

Filed Under: Blog, Dialysis, Food & Drug Administration (FDA), Materials Testing, News Well, Regulatory/Compliance Tagged With: FDA, Fresenius Medical Care

FDA approves magnetic resonance labeling for CVRx’s Barostim neuromodulation system

May 9, 2022 By Sean Whooley

CVRx (Nasdaq:CVRX) announced today that the FDA approved magnetic resonance (MR) conditional labeling for its Barostim system. The Barostim neuromodulation system for treating the symptoms of heart failure now includes instructions to allow for safe MRI scans of the head and lower extremities, offering heart failure patients implanted with Barostim more diagnostic options. Minneapolis-based CVRx […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), Imaging, Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Regulatory/Compliance Tagged With: cvrx, CVRx Inc., FDA

FDA clears Philips’ MR 7700 imaging system

May 9, 2022 By Sean Whooley

Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its new MR 7700 3.0T MR imaging system. Amsterdam-based Philips said it designed the MR 7700 system to provide high accuracy to support clinical diagnostics through high-quality diffusion imaging and advanced neuroscience. The company said in a news release that MR 7700 expands scanning […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Health Technology, Imaging, Neurological, News Well, Radiosurgery/Radiation therapy, Regulatory/Compliance, Software / IT Tagged With: FDA, Philips, Royal Philips

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 117
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS